retatrutide for menopause Retatrutide: A Promising Solution Weight Gain? Retatrutide - Seenergie PH

The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin

However, this also comes with: Higher efficacy: Substantially greater weight loss More side effects: Increased GI symptoms and dysesthesia Unknown long-term effects: Retatrutide's extended safety profile is still being evaluated What's Next: The TRIUMPH Program Timeline TRIUMPH-4 is just the beginning

What Does Retatrutide Actually Treat

Nestle targeted GLP-1 users when it launched its Vital Pursuit frozen meal brand in the fall of 2024

Examples include Ozempic, Wegovy, Mounjaro, and Zepbound